ALNY
Alnylam Pharmaceuticals Inc
219.70$
-5.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.86 | -13.61 | -1.65 | -0.75 | -0.77 | 5.08 | 1.59 | -1.73 | -2.01 | -2.05 | -2.30 | -1.12 | -2.23 | -2.25 | -3.59 | -4.23 | -5.59 | -2.55 | -5.35 | -5.42 | -4.45 | 0.83 | -0.07 | 3.89 | |
| 0.11 | 0.89 | 0.21 | 0.14 | 0.12 | 0.11 | 0.14 | 0.14 | 0.12 | 0.12 | 0.18 | 0.17 | 0.16 | 0.23 | 0.18 | 0.15 | 0.06 | 0.50 | 0.65 | 0.76 | 0.70 | 0.78 | 0.44 | 0.41 | |
| – | – | 0.35 | – | 0.26 | 0.37 | 0.44 | 0.48 | 0.46 | 0.40 | 0.25 | 0.34 | 0.45 | 0.55 | 0.88 | 1.03 | 1.57 | 1.60 | 1.22 | 1.40 | 1.90 | 1.77 | 2.13 | 2.59 | |
| – | – | – | – | – | 0.09 | 0.06 | – | 0.61 | 0.49 | -0.16 | 0.34 | -0.09 | 0.56 | 0.84 | 1.08 | 1.85 | 1.85 | 1.36 | 1.89 | 2.53 | – | – | – | |
| 8.00 | 3.08 | 0.29 | 0.76 | -0.08 | 6.58 | 1.56 | -1.21 | -1.89 | -1.32 | -0.18 | -0.13 | -0.40 | 0.42 | 0.20 | -0.03 | 0.45 | 3.68 | -0.11 | -1.37 | -0.29 | 0.09 | -1.68 | -3.30 | |
| 1.70 | 3.31 | 0.76 | 0.09 | 0.16 | 0.20 | 0.26 | 0.12 | 0.11 | 0.03 | 0.17 | 0.07 | 0.12 | 0.15 | 0.75 | 1.15 | 1.26 | 1.28 | 0.61 | 0.64 | 0.59 | 0.50 | 0.27 | 0.44 | |
| -1.70 | -3.44 | -2.91 | -1.84 | -0.94 | -7.18 | 0.44 | 0.35 | 0.42 | 1.93 | 0.07 | -2.12 | -7.39 | -3.83 | 1.67 | -3.21 | 2.71 | -3.82 | -3.79 | -2.31 | 1.39 | -2.69 | -0.92 | 3.24 | |
| – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 0.09 | 0.02 | -0.01 | -0.02 | -0.22 | 0.00 | -0.01 | 0.00 | -0.03 | 7.81 | 2.61 | 2.08 | 2.13 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | 2.02 | 1.79 | 1.75 | -1.33 | -0.30 | -0.27 | 1.74 | 4.22 | 2.09 | 0.00 | 0.00 | -4.04 | |
| 52.26 | 25.15 | 4.29 | 2.40 | 5.23 | 1.52 | 0.08 | 0.08 | 0.09 | 0.02 | 1.86 | 3.26 | 9.91 | 7.34 | 2.08 | 12.42 | 0.65 | 7.53 | 8.65 | 10.53 | 3.50 | 1.38 | 2.30 | -2.27 | |
| 52.26 | 8.19 | -0.25 | -0.21 | 3.52 | -0.59 | 2.11 | -1.30 | -1.50 | -0.10 | -0.37 | 0.03 | 0.30 | 1.26 | 0.15 | 4.99 | -2.23 | 1.16 | -0.44 | 2.73 | 0.38 | -0.43 | 1.20 | 5.12 | |
| -5.55 | -16.92 | -2.40 | -0.84 | -0.93 | 4.88 | 1.33 | -1.85 | -2.12 | -2.08 | -2.47 | -1.18 | -2.35 | -2.41 | -4.35 | -5.38 | -6.85 | -3.83 | -5.96 | -6.06 | -5.04 | 0.34 | -0.33 | 3.46 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.